Long Term Care Journal
Wednesday, January 16, 2019
FDA approves first generic version of Sabril to help treat seizures in adults and pediatric patients with epilepsy - FDA Press Releases
FDA approved the first generic version of Sabril for treating complex partial seizures, as an adjunctive therapy in certain patients.
from Food and Drug Administration--Press Releases http://bit.ly/2QT7Olr
via
IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment